Ventech Capital III already has six portfolio companies, including
Ventech invests principally in France, but has also made significant investments in Germany and Switzerland, in particular in life sciences. The Ventech team also occasionally looks at investment opportunities in the US and Israel.
Outside France, Ventech has made it a rule always to invest alongside a first-rate local partner, as investing in start-ups requires the close monitoring of investments and an intimate knowledge of the country’s social, legal and economic environment.
With its third fund, Ventech now has €325m under management including the funds Ventech II (€112m) and Ventech I (€62m). Successes from these funds include MeilleurTaux, the first company to IPO on the Alternext Market at €150m, with a 15x multiple; Musiwave, sold to Openwave for US$120m with a 10x multiple; and Alantos Pharmaceuticals, sold for US$300m to Amgen generating a 5.5x.
Global Private Equity acted as placement agent for the new fund.